Lymphatic Endothelial Cells Antibody (LA102) [DyLight 350]

• Reactivity: Mu
• Applications: WB, ICC/IF, IHC
• Clone: LA102
• Clonality: Monoclonal
• Host: Rat
• Conjugate: DyLight 350

Lymphatic Endothelial Cells Antibody (LA102) [DyLight 350] Summary

• Immunogen: Collagenase- and neuraminidase-treated mouse benign lymphangiomas
• Specificity: LA102 reacts with mouse lymphatic vessels except the thoracic duct and the marginal sinus of lymph nodes, but not with any blood vessels. LA102 recognized a protein of around 26 kDa.The antigen recognized by LA102 was localized on both luminal and abluminal lymphatic endothelial cell membranes. Besides lymphatics, some lymphoid cells are also recognized.
• Isotype: IgG2b
• Clonality: Monoclonal
• Host: Rat
• Purity: Protein G purified

Applications/Dilutions

• Dilutions:
  • Immunocytochemistry/ Immunofluorescence
  • Immunohistochemistry
  • Immunohistochemistry-Frozen
  • Western Blot

Packaging, Storage & Formulations

• Storage: Store at 4C in the dark.
• Buffer: 50mM Sodium Borate
• Preservative: 0.05% Sodium Azide
• Purity: Protein G purified

Notes

DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.

Alternate Names for Lymphatic Endothelial Cells Antibody (LA102) [DyLight 350]

• LEC26

Background

The antibody was produced by a rapid differential immunization of DA rats (licenced from Tokyo Women's Medical University, Japan.) with collagenase and neuraminidasetreated mouse lymphatic vessels except the thoracic duct and the marginal sinus of lymph nodes, but not with any blood vessels. LA102 recognized a protein of around 26 kDa. The antigen recognized by LA102 was localized on both luminal and abluminal lymphatic endothelial cell membranes. Besides lymphatics, some lymphoid cells are also recognized.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.